A meta-analysis comprising 41 studies and 6517 patients with primary breast cancer reported that MMP2 and MMP9 overexpression conferred a higher risk of distant and lymph node metastasis, respectively, and were both associated with higher clinical stage and histological grade (26). Here, MMP9 is linked to breast carcinoma.